Digital transformation has become an increasingly important topic for the biopharmaceutical industry, as it generates new opportunities for creating additional value and takes advantage of the essential competitive advantage. Digital bio-manufacturing leverages the Internet to connect different sources of data, equipment, materials and people. In combination with artificial intelligence, augmented reality, robotics and digital twins, Biopharma 4.0 changes the concepts inherited from the beginning.

The benefits arise throughout the entire value chain, from the development of new candidates to products and associated manufacturing processes, to regulatory aspects, market approval, manufacturing, quality and much more: